Veradigm (NASDAQ:MDRX) Coverage Initiated at StockNews.com

Investment analysts at StockNews.com initiated coverage on shares of Veradigm (NASDAQ:MDRXGet Free Report) in a note issued to investors on Sunday. The brokerage set a “hold” rating on the software maker’s stock.

Separately, TD Cowen reduced their target price on shares of Veradigm from $26.00 to $15.00 and set a “buy” rating on the stock in a research report on Tuesday, May 28th. Four research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, Veradigm presently has an average rating of “Hold” and a consensus target price of $12.00.

Read Our Latest Research Report on MDRX

Veradigm Price Performance

NASDAQ MDRX opened at $9.75 on Friday. The company’s fifty day simple moving average is $9.66 and its 200-day simple moving average is $8.85. Veradigm has a 52 week low of $5.01 and a 52 week high of $14.09.

Institutional Trading of Veradigm

A number of hedge funds and other institutional investors have recently made changes to their positions in MDRX. Vanguard Group Inc. increased its stake in Veradigm by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 14,275,875 shares of the software maker’s stock valued at $149,754,000 after purchasing an additional 95,291 shares during the last quarter. Wellington Management Group LLP raised its position in Veradigm by 117.8% in the fourth quarter. Wellington Management Group LLP now owns 5,806,297 shares of the software maker’s stock worth $60,908,000 after acquiring an additional 3,140,483 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in Veradigm by 6.6% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,596,684 shares of the software maker’s stock valued at $16,749,000 after acquiring an additional 99,528 shares during the last quarter. Tyro Capital Management LLC acquired a new stake in Veradigm in the 1st quarter valued at about $9,055,000. Finally, Allianz Asset Management GmbH grew its stake in shares of Veradigm by 41.2% in the 4th quarter. Allianz Asset Management GmbH now owns 343,433 shares of the software maker’s stock worth $3,603,000 after purchasing an additional 100,275 shares during the last quarter.

About Veradigm

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Featured Articles

Analyst Recommendations for Veradigm (NASDAQ:MDRX)

Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.